TABLE 2.

Outcomes between hemodialysis patients with/without previous peritoneal dialysis.

Outcomes	Transitioned from PD		HD-only		Transitioned from PD vs. HD-only
	Events	IR	Events	IR	Crude		Multivariable
					HR	P	aHR*	P
					(95%CI)		(95%CI)
All-cause Death	385	12.6	1,310	8.93	1.39	< 0.001	1.36	< 0.001
					(1.24–1.56)		(1.21–1.53)
All-cause hospitalization	680	52.2	3,145	43.5	1.01	0.824	1.07	0.219
					(0.91–1.12)		(0.96–1.18)
Infection-related admission	269	11.7	1,272	11	1.07	0.435	0.97	0.781
					(0.89–1.30)		(0.80–1.18)
MACE	200	7.6	942	7.4	0.93	0.49	0.91	0.372
					(0.75–1.14)		(0.73–1.12)

*Further adjusted comorbidities (hypertension, diabetes mellitus, coronary artery disease, congestive heart failure, atrial fibrillation, peripheral vascular disease, stroke, chronic obstructive pulmonary disease, hyperlipidemia, polycystic kidney) and medications (renin-angiotensin system blockades, beta-blocker, calcium channel blockers, anti-coagulants, dipeptidyl peptidase-4, and Lipid-lowering agents).

PD, peritoneal dialysis; HD, hemodialysis; IR, incidence rate (every 100 person-years); HR, hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval; MACE, major adverse cardiovascular events.